Genexine, Inc. (KOSDAQ:095700)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,440.00
-150.00 (-2.28%)
Jul 18, 2025, 3:30 PM KST

Genexine Revenue

Genexine had revenue of 2.07B KRW in the quarter ending March 31, 2024, with 199.63% growth. This brings the company's revenue in the last twelve months to 5.81B, down -3.50% year-over-year. In the year 2023, Genexine had annual revenue of 4.43B, down -72.57%.

Revenue (ttm)
5.81B
Revenue Growth
-3.50%
P/S Ratio
50.43
Revenue / Employee
67.53M
Employees
86
Market Cap
292.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20234.43B-11.71B-72.57%
Dec 31, 202216.14B-20.69B-56.18%
Dec 31, 202136.83B18.28B98.61%
Dec 31, 202018.54B7.24B64.06%
Dec 31, 201911.30B5.05B80.80%
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
HLB Co., Ltd.74.64B
Peptron4.30B
PharmaResearch392.31B
Revenue Rankings